Healthtech Capital Announces Two New Investments In The Emerging Healthtech Market

LOS ALTOS HILLS, CA – September 15, 2011

HealthTech Capital, a Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market, announced today that it has closed two new investment deals. PharmaSecure received around $400,000 from HealthTech Capital members in a Series B syndicated venture round that included Gray Ghost Ventures and others, while Niveus Medical received over $600,000 in a Series A syndicated financing of approximately $2 million, which also included Band of Angels, Life Science Angels, Sand Hill Angels, and other angel and venture capital groups. Today’s announcement underscores the growing use of investment syndications to support early-stage companies that reduce healthcare costs through technology innovation.

“With healthcare costs continuing to spiral out of control, companies that decrease costs by leveraging new technologies are providing very attractive investment opportunities,” said Anne DeGheest, a HealthTech pioneer with her firm Medstars and a cofounder and managing director of HealthTech Capital. “PharmaSecure and Niveus Medical are well positioned to be the next wave of successful HealthTech companies, and we are delighted to work closely with such great entrepreneurs.”

With healthcare costs continuing to spiral out of control, companies that decrease costs by leveraging new technologies are providing very attractive investment opportunities.

Anne DeGheest,
cofounder and managing director
of HealthTech Capital.

“With the early-stage funding gap, HealthTech Capital is stepping up to syndicate, or pool, investments with other angel groups to fund early-stage companies,” said Don Ross, HealthTech Capital cofounder and managing director and Sand Hill Angels board director. “In addition, HealthTech Capital accelerates its portfolio companies through their early stages by providing hands-on mentoring as well as investment dollars. With both PharmaSecure and Niveus Medical, HealthTech Capital members became involved long before the investments and will continue to provide added-value mentoring going forward.”

PharmaSecure uses cell phone technology to combat the global problem of counterfeit drugs. On each bubble pack of pills, the company prints a unique code and phone number so consumers can verify the drug’s authenticity with an SMS text message. PharmaSecure has significant traction in India, driven by recent legislation changes.

“HealthTech Capital’s leadership and members are experienced investors with in-depth understanding of healthcare and technology and the intersection of the two industries,” said Nathan Sigworth, CEO of PharmaSecure. “We are pleased that our product is achieving such global acceptance and appreciate having HealthTech Capital as an investor to help us with product expansion.”

Niveus Medical is developing a technology to preserve muscle strength during long periods of sedation and bed rest. By reducing muscle debilitation, the company intends to shorten hospital stays, especially time in the intensive care unit, and provide significant cost savings.

“We are delighted to have HealthTech’s participation in this funding round, which will help us validate the benefits our technology brings to patients, as well as the cost savings it can deliver to the healthcare system,” said Brian J. Fahey, CEO of Niveus Medical.

About PharmaSecure

PharmaSecure is a global innovator in drug authentication technologies and software, creating effective solutions to ensure consumers receive authentic medications from trusted pharmaceutical manufacturers in emerging markets. Founded in 2007, PharmaSecure is a fast-growing company offering services in the United States, Europe, India, Africa, and Southeast Asia. The company is based in Lebanon, NH.

About Niveus Medical

Niveus Medical has developed a series of novel technologies to reduce or prevent debilitation and thereby accelerate patient recovery, shorten hospital stays, and reduce both hospital and payer costs. The company’s solution is the first to prevent muscle deterioration in patients who are sedated and cannot participate in physical therapy. Early testing shows Niveus technologies to be easily used by nursing staff and well-accepted by patients. Niveus Medical is based in Palo Alto, Calif.

About HealthTech Capital

HealthTech Capital is a leading Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market where digital innovation improves healthcare delivery and empowers patients. HealthTech Capital is led by proven investors and visionaries in health care and technology. Its members are industry leaders – successful entrepreneurs, executives, physicians and venture capitalists – with expertise in healthcare and new information and mobile technologies. In addition to funding and mentoring new companies, the group facilitates syndication with other angel investors, venture capitalists and corporations for funding and other opportunities. For more information on HealthTech Capital, please visit www.HealthTechCapital.com.

Tracy Morris
(o) 650-473-1272
(c) 650-380-4413
tracy@morrismarcom.com

EVENTS

05 June 2018 CIMED Israeli Medtech and Healthtech

Anne DeGheest will be a judge at Cimed on June 19, 2018 in Menlo Park. Come join me to see exciting new medical devices and HealthTech companies coming from Israel. Use code Medstar40 for 40% discount

05 June 2018 Boomer Summit June 20-21, 2018

Anne DeGheest will be on a panel at the Boomer summit in Berkeley on june 20 and 21, 2018.

@HealthTechCap is a proud sponsor of the Silicon Valley @SiliconBoomer Summit 6/20-21.

Use code sv18healthtech20 more at https://lnkd.in/eeJVJmu https://lnkd.in/eMHmrD7

17 March 2018 Boomer summit March 27-28, 2018

I’ll be one of the featured speakers at the What’s Next #Boomer Summit in San Francisco, CA. March 27-28 in San Francisco Use my 20% discount code: WH18FOM

04 March 2018 HAAS Healthcare Conference 2018

When: March 9, 2018 from 3 to 3:50pm

Location: SF Mission Bay Conference Center

  • 1675 Owens Street #251, San Francisco, CA, 94158

Panel: Consumerization 2.0

  • Anne DeGheest (our moderator) - Founder and Managing Director at HealthTech Capital and Medstars
  • Naomi Kelman - President and CEO at Willow,
  • Dr. Cameron Sepah - Founder and CEO at Actualize and Entrepreneur in Residence at Trinity Ventures, 
  • Adam Kovalevsky - SVP Product, Engineering, and Design at Collective Health 
  • Yasi Baiani - Head of Product Management, Software Experiences, Fitbit


RSS

© 2011 HealthTech Capital. All Rights Reserved. Designed by Night River